Related Experiment Videos
Sequence variation database project at the European Bioinformatics Institute
H Lehväslaiho1, E Stupka, M Ashburner
1EMBL Outstation, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. heikki@ebi.ac.uk
Human Mutation
|December 29, 1999
Summary
The European Bioinformatics Institute (EBI) is developing a unified sequence variation database. Challenges include intellectual property rights, with copylefting proposed as a solution for data sharing.
Area of Science:
- Bioinformatics
- Genomics
- Data Management
Background:
- Existing mutation databases are fragmented and difficult to unify.
- Sequence variation data is crucial for understanding genetic diseases and evolution.
- Intellectual property rights pose significant barriers to data integration.
Purpose of the Study:
- To report on the technical advances in creating a unified sequence variation resource at EBI.
- To identify and address the challenges in unifying disparate mutation databases.
- To explore potential solutions for overcoming intellectual property barriers in data sharing.
Main Methods:
- Developing methods for ingesting and validating diverse sequence variation data types.
- Implementing cross-referencing protocols for data consistency.
- Analyzing the impact of intellectual property rights on database unification.
Main Results:
- Technical advancements have been made in data processing and validation.
- The EBI sequence variation project is progressing towards a unified resource.
- Intellectual property rights are identified as the primary obstacle.
Conclusions:
- The unification of mutation databases is technically feasible but hindered by legal and IP issues.
- Copylefting is proposed as a viable strategy to facilitate data sharing and overcome IP restrictions.
- A unified sequence variation resource will enhance genomic research and data accessibility.